VJOncology is committed to improving our service to you

ASCO 2020 | DS-8201 + pembro in patients HER2+ breast and NSCLC

VJOncology is committed to improving our service to you

Sanjay Popat

Sanjay Popat, BSc, MBBS, FRCP, PhD, The Royal Marsden NHS Foundation Trust, London, UK, discusses data from a phase II study which evaluated the use of trastuzumab deruxtecan in combination with pembrolizumab in patients with advanced/metastatic breast or non-small cell lung cancer (NSCLC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter